The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vascular Bioprostheses-Global Market Insights and Sales Trends 2025
Synopsis
Vascular bioprostheses are artificial blood vessels made from biological materials, such as animal tissues or synthetic polymers, used to replace damaged or diseased blood vessels. They are employed in surgical interventions to treat vascular diseases or repair blood vessel defects.
The global Vascular Bioprostheses market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vascular Bioprostheses in various end use industries. The expanding demands from the Arterial Disease, Venous Disease and Arteriovenous Fistula,, are propelling Vascular Bioprostheses market. Aortic Vessel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Y-shaped Vessel segment is estimated at % CAGR for the next seven-year period.
The market for vascular bioprostheses is influenced by factors such as the increasing prevalence of vascular diseases, advancements in tissue engineering, and the demand for minimally invasive vascular procedures. The aging population and lifestyle-related risk factors also contribute to the market's growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vascular Bioprostheses, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vascular Bioprostheses market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vascular Bioprostheses market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vascular Bioprostheses sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vascular Bioprostheses covered in this report include Braile Biomedica, Humacyte, Sorin, Wuhan Youngsen Biotech, B. Braun, W. L. Gore, LivaNova PLC, Medtronic and LabCorp, etc.
The global Vascular Bioprostheses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Braile Biomedica
Humacyte
Sorin
Wuhan Youngsen Biotech
B. Braun
W. L. Gore
LivaNova PLC
Medtronic
LabCorp
CryoLife
LeMaitre Vascular, Inc.
Affluent Medical
Perouse
Global Vascular Bioprostheses market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vascular Bioprostheses market, Segment by Type:
Aortic Vessel
Y-shaped Vessel
Limb Vone Vessel
Limb Arteries
Global Vascular Bioprostheses market, by Application
Arterial Disease
Venous Disease
Arteriovenous Fistula
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vascular Bioprostheses manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vascular Bioprostheses in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Vascular bioprostheses are artificial blood vessels made from biological materials, such as animal tissues or synthetic polymers, used to replace damaged or diseased blood vessels. They are employed in surgical interventions to treat vascular diseases or repair blood vessel defects.
The global Vascular Bioprostheses market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vascular Bioprostheses in various end use industries. The expanding demands from the Arterial Disease, Venous Disease and Arteriovenous Fistula,, are propelling Vascular Bioprostheses market. Aortic Vessel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Y-shaped Vessel segment is estimated at % CAGR for the next seven-year period.
The market for vascular bioprostheses is influenced by factors such as the increasing prevalence of vascular diseases, advancements in tissue engineering, and the demand for minimally invasive vascular procedures. The aging population and lifestyle-related risk factors also contribute to the market's growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vascular Bioprostheses, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vascular Bioprostheses market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vascular Bioprostheses market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vascular Bioprostheses sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vascular Bioprostheses covered in this report include Braile Biomedica, Humacyte, Sorin, Wuhan Youngsen Biotech, B. Braun, W. L. Gore, LivaNova PLC, Medtronic and LabCorp, etc.
The global Vascular Bioprostheses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Braile Biomedica
Humacyte
Sorin
Wuhan Youngsen Biotech
B. Braun
W. L. Gore
LivaNova PLC
Medtronic
LabCorp
CryoLife
LeMaitre Vascular, Inc.
Affluent Medical
Perouse
Global Vascular Bioprostheses market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vascular Bioprostheses market, Segment by Type:
Aortic Vessel
Y-shaped Vessel
Limb Vone Vessel
Limb Arteries
Global Vascular Bioprostheses market, by Application
Arterial Disease
Venous Disease
Arteriovenous Fistula
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vascular Bioprostheses manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vascular Bioprostheses in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Vascular Bioprostheses Market Overview
1.1 Vascular Bioprostheses Product Overview
1.2 Vascular Bioprostheses Market Segment by Type
1.2.1 Aortic Vessel
1.2.2 Y-shaped Vessel
1.2.3 Limb Vone Vessel
1.2.4 Limb Arteries
1.3 Global Vascular Bioprostheses Market Size by Type
1.3.1 Global Vascular Bioprostheses Market Size Overview by Type (2018-2029)
1.3.2 Global Vascular Bioprostheses Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vascular Bioprostheses Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vascular Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vascular Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vascular Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vascular Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vascular Bioprostheses Sales Breakdown by Type (2018-2023)
2 Global Vascular Bioprostheses Market Competition by Company
2.1 Global Top Players by Vascular Bioprostheses Sales (2018-2023)
2.2 Global Top Players by Vascular Bioprostheses Revenue (2018-2023)
2.3 Global Top Players by Vascular Bioprostheses Price (2018-2023)
2.4 Global Top Manufacturers Vascular Bioprostheses Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vascular Bioprostheses Market Competitive Situation and Trends
2.5.1 Vascular Bioprostheses Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vascular Bioprostheses Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vascular Bioprostheses as of 2022)
2.7 Date of Key Manufacturers Enter into Vascular Bioprostheses Market
2.8 Key Manufacturers Vascular Bioprostheses Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vascular Bioprostheses Status and Outlook by Region
3.1 Global Vascular Bioprostheses Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vascular Bioprostheses Historic Market Size by Region
3.2.1 Global Vascular Bioprostheses Sales in Volume by Region (2018-2023)
3.2.2 Global Vascular Bioprostheses Sales in Value by Region (2018-2023)
3.2.3 Global Vascular Bioprostheses Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vascular Bioprostheses Forecasted Market Size by Region
3.3.1 Global Vascular Bioprostheses Sales in Volume by Region (2024-2029)
3.3.2 Global Vascular Bioprostheses Sales in Value by Region (2024-2029)
3.3.3 Global Vascular Bioprostheses Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vascular Bioprostheses by Application
4.1 Vascular Bioprostheses Market Segment by Application
4.1.1 Arterial Disease
4.1.2 Venous Disease
4.1.3 Arteriovenous Fistula
4.2 Global Vascular Bioprostheses Market Size by Application
4.2.1 Global Vascular Bioprostheses Market Size Overview by Application (2018-2029)
4.2.2 Global Vascular Bioprostheses Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vascular Bioprostheses Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vascular Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vascular Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vascular Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vascular Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vascular Bioprostheses Sales Breakdown by Application (2018-2023)
5 North America Vascular Bioprostheses by Country
5.1 North America Vascular Bioprostheses Historic Market Size by Country
5.1.1 North America Vascular Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vascular Bioprostheses Sales in Volume by Country (2018-2023)
5.1.3 North America Vascular Bioprostheses Sales in Value by Country (2018-2023)
5.2 North America Vascular Bioprostheses Forecasted Market Size by Country
5.2.1 North America Vascular Bioprostheses Sales in Volume by Country (2024-2029)
5.2.2 North America Vascular Bioprostheses Sales in Value by Country (2024-2029)
6 Europe Vascular Bioprostheses by Country
6.1 Europe Vascular Bioprostheses Historic Market Size by Country
6.1.1 Europe Vascular Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vascular Bioprostheses Sales in Volume by Country (2018-2023)
6.1.3 Europe Vascular Bioprostheses Sales in Value by Country (2018-2023)
6.2 Europe Vascular Bioprostheses Forecasted Market Size by Country
6.2.1 Europe Vascular Bioprostheses Sales in Volume by Country (2024-2029)
6.2.2 Europe Vascular Bioprostheses Sales in Value by Country (2024-2029)
7 Asia-Pacific Vascular Bioprostheses by Region
7.1 Asia-Pacific Vascular Bioprostheses Historic Market Size by Region
7.1.1 Asia-Pacific Vascular Bioprostheses Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vascular Bioprostheses Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vascular Bioprostheses Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vascular Bioprostheses Forecasted Market Size by Region
7.2.1 Asia-Pacific Vascular Bioprostheses Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vascular Bioprostheses Sales in Value by Region (2024-2029)
8 Latin America Vascular Bioprostheses by Country
8.1 Latin America Vascular Bioprostheses Historic Market Size by Country
8.1.1 Latin America Vascular Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vascular Bioprostheses Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vascular Bioprostheses Sales in Value by Country (2018-2023)
8.2 Latin America Vascular Bioprostheses Forecasted Market Size by Country
8.2.1 Latin America Vascular Bioprostheses Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vascular Bioprostheses Sales in Value by Country (2024-2029)
9 Middle East and Africa Vascular Bioprostheses by Country
9.1 Middle East and Africa Vascular Bioprostheses Historic Market Size by Country
9.1.1 Middle East and Africa Vascular Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vascular Bioprostheses Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vascular Bioprostheses Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vascular Bioprostheses Forecasted Market Size by Country
9.2.1 Middle East and Africa Vascular Bioprostheses Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vascular Bioprostheses Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Braile Biomedica
10.1.1 Braile Biomedica Company Information
10.1.2 Braile Biomedica Introduction and Business Overview
10.1.3 Braile Biomedica Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Braile Biomedica Vascular Bioprostheses Products Offered
10.1.5 Braile Biomedica Recent Development
10.2 Humacyte
10.2.1 Humacyte Company Information
10.2.2 Humacyte Introduction and Business Overview
10.2.3 Humacyte Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Humacyte Vascular Bioprostheses Products Offered
10.2.5 Humacyte Recent Development
10.3 Sorin
10.3.1 Sorin Company Information
10.3.2 Sorin Introduction and Business Overview
10.3.3 Sorin Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sorin Vascular Bioprostheses Products Offered
10.3.5 Sorin Recent Development
10.4 Wuhan Youngsen Biotech
10.4.1 Wuhan Youngsen Biotech Company Information
10.4.2 Wuhan Youngsen Biotech Introduction and Business Overview
10.4.3 Wuhan Youngsen Biotech Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Wuhan Youngsen Biotech Vascular Bioprostheses Products Offered
10.4.5 Wuhan Youngsen Biotech Recent Development
10.5 B. Braun
10.5.1 B. Braun Company Information
10.5.2 B. Braun Introduction and Business Overview
10.5.3 B. Braun Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.5.4 B. Braun Vascular Bioprostheses Products Offered
10.5.5 B. Braun Recent Development
10.6 W. L. Gore
10.6.1 W. L. Gore Company Information
10.6.2 W. L. Gore Introduction and Business Overview
10.6.3 W. L. Gore Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.6.4 W. L. Gore Vascular Bioprostheses Products Offered
10.6.5 W. L. Gore Recent Development
10.7 LivaNova PLC
10.7.1 LivaNova PLC Company Information
10.7.2 LivaNova PLC Introduction and Business Overview
10.7.3 LivaNova PLC Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.7.4 LivaNova PLC Vascular Bioprostheses Products Offered
10.7.5 LivaNova PLC Recent Development
10.8 Medtronic
10.8.1 Medtronic Company Information
10.8.2 Medtronic Introduction and Business Overview
10.8.3 Medtronic Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Medtronic Vascular Bioprostheses Products Offered
10.8.5 Medtronic Recent Development
10.9 LabCorp
10.9.1 LabCorp Company Information
10.9.2 LabCorp Introduction and Business Overview
10.9.3 LabCorp Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.9.4 LabCorp Vascular Bioprostheses Products Offered
10.9.5 LabCorp Recent Development
10.10 CryoLife
10.10.1 CryoLife Company Information
10.10.2 CryoLife Introduction and Business Overview
10.10.3 CryoLife Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CryoLife Vascular Bioprostheses Products Offered
10.10.5 CryoLife Recent Development
10.11 LeMaitre Vascular, Inc.
10.11.1 LeMaitre Vascular, Inc. Company Information
10.11.2 LeMaitre Vascular, Inc. Introduction and Business Overview
10.11.3 LeMaitre Vascular, Inc. Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.11.4 LeMaitre Vascular, Inc. Vascular Bioprostheses Products Offered
10.11.5 LeMaitre Vascular, Inc. Recent Development
10.12 Affluent Medical
10.12.1 Affluent Medical Company Information
10.12.2 Affluent Medical Introduction and Business Overview
10.12.3 Affluent Medical Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Affluent Medical Vascular Bioprostheses Products Offered
10.12.5 Affluent Medical Recent Development
10.13 Perouse
10.13.1 Perouse Company Information
10.13.2 Perouse Introduction and Business Overview
10.13.3 Perouse Vascular Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Perouse Vascular Bioprostheses Products Offered
10.13.5 Perouse Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vascular Bioprostheses Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vascular Bioprostheses Industrial Chain Analysis
11.4 Vascular Bioprostheses Market Dynamics
11.4.1 Vascular Bioprostheses Industry Trends
11.4.2 Vascular Bioprostheses Market Drivers
11.4.3 Vascular Bioprostheses Market Challenges
11.4.4 Vascular Bioprostheses Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vascular Bioprostheses Distributors
12.3 Vascular Bioprostheses Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
